[EN] OXIME CARBAMOYL DERIVATIVES AS MODULATORS OF FATTY ACID AMIDES HYDROLASE<br/>[FR] DÉRIVÉS CARBAMOYLES D'OXIMES COMME MODULATEURS DE L'HYDROLASE DES AMIDES D'ACIDES GRAS
申请人:SIGMA TAU IND FARMACEUTI
公开号:WO2009138416A1
公开(公告)日:2009-11-19
The present invention relates to new oxime carbamoyl derivatives of formula (I), processes for their preparation, and to pharmaceutical compositions containing them for the treatment of neurological disorders, such as neuropathic pain and anxiety.
A series of oxime carbamates have been identified as potent inhibitors of fattyacidamidehydrolase (FAAH), an important regulatory enzyme of the endocannabinoid signaling system. Kinetic analysis indicates that they behave as non-competitive, reversible inhibitors, and show remarkable selectivity for FAAHover the other components of the endocannabinoidsystem.